Lv11
18 积分 2024-06-17 加入
OS-030 Efficacy and safety of xalnesiran with and without an immunomodulator in virologically suppressed participants with chronic hepatitis B: end of study results from the phase 2, randomized, controlled, adaptive, open-label platform study (PIRANGA)
2小时前
待确认
The discovery and development of RNA-based therapies for treatment of HIV-1 infection
1个月前
已完结
Genotoxicity testing of biotechnology-derived products
7个月前
已完结
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus
8个月前
已完结
Current Advances in Vaccine Development for Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV)
9个月前
已完结
Phylogenetic and Geographic Relationships of Severe Fever With Thrombocytopenia Syndrome Virus in China, South Korea, and Japan
9个月前
已完结
Hepatitis B surface antigen quantification in chronic hepatitis B and its clinical utility
10个月前
已关闭
Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B
10个月前
已完结
Protected or not? Hepatitis B vaccination status among healthcare workers and the level of protection post-vaccination
11个月前
已完结
Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis
1年前
已完结
皖公网安备34019202002308
